A Role for Brain-Specific Homeobox Factor Bsx in the Control of Hyperphagia and Locomotory Behavior  by Sakkou, Maria et al.
Cell Metabolism
ArticleA Role for Brain-Specific Homeobox Factor
Bsx in the Control of Hyperphagia and
Locomotory Behavior
Maria Sakkou,1 Petra Wiedmer,2 Katrin Anlag,1 Anne Hamm,1 Eve Seuntjens,1,4 Laurence Ettwiller,1
Matthias H. Tscho¨p,2,3 and Mathias Treier1,*
1 Developmental Biology Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany
2 German Institute of Human Nutrition, Potsdam-Rehbruecke, Department of Pharmacology, A.-Scheunert-Allee 114-116, 14558
Nuthetal, Germany
3 Department of Psychiatry, University of Cincinnati, Obesity Research Centre - Genome Research Institute, 2170 E Galbraith
Road, Cincinnati, OH 45237, USA
4 Present address: Laboratory of Molecular Biology (Celgen), Department of Molecular and Developmental Genetics, K.U.Leuven,
Gasthuisberg O&N1, Herestraat 49, 3000 Leuven, Belgium.
*Correspondence: treier@embl.de
DOI 10.1016/j.cmet.2007.05.007SUMMARY
Food intake and activity-induced thermogene-
sis are important components of energy bal-
ance regulation. The molecular mechanism
underlying the coordination of food intake with
locomotory behavior to maintain energy ho-
meostasis is unclear. We report that the brain-
specific homeobox transcription factor Bsx is
required for locomotory behavior, hyperphagia,
and expression of the hypothalamic neuro-
peptides Npy and Agrp, which regulate feeding
behavior and body weight. Mice lacking Bsx
exhibit reduced locomotor activity and lower
expression of Npy and Agrp. They also exhibit
attenuated physiological responses to fasting,
including reduced increase of Npy/Agrp ex-
pression, lack of food-seeking behavior, and
reduced rebound hyperphagia. Furthermore,
Bsx gene disruption rescues the obese pheno-
type of leptin-deficient ob/ob mice by reducing
their hyperphagia without increasing their loco-
motor activity. Thus, Bsx represents an essen-
tial factor for NPY/AgRP neuronal function and
locomotory behavior in the control of energy
balance.
INTRODUCTION
Obesity is the result of positive energy balance, where ca-
loric intake exceeds caloric expenditure over time. Since
the brain plays a crucial role in the regulation of energy bal-
ance, a better understanding of the neuronal mechanisms
required to maintain energy homeostasis is of outmost im-
portance (Flier, 2004; Friedman, 2004; Morton et al., 2006;
Schwartz and Porte, 2005).450 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier InThe arcuate nucleus (ARC) of the hypothalamus har-
bors two distinct neuronal populations, which each re-
ceive multiple afferent signals conveying information
about energy metabolism. ‘‘Orexigenic’’ neuropeptide
Y / agouti-related peptide (NPY/AgRP) neurons promote
weight gain, and they increase the secretion of other orexi-
genic neuropeptides including melanin-concentrating
hormone (MCH) and hypocretin/orexin from the lateral hy-
pothalamus. NPY/AgRP neurons are directly inhibited by
leptin. In contrast, ‘‘anorexigenic’’ pro-opiomelanocortin
(POMC) neurons inhibit food intake and promote weight
loss in a leptin-dependent manner via a- and b-melano-
cyte stimulating hormones (aMSH and b-MSH), prod-
ucts of POMC processing (Barsh and Schwartz, 2002;
Lee et al., 2006). Many other satiety and hunger signals
are sensed by these neurons, including ghrelin, insulin,
glucose, and fatty acids (Badman and Flier, 2005). Both
neuronal populations send dense projections to other
neurons involved in energy metabolism located in the par-
aventricular nucleus (PVN), zona incerta, perifornical area
and lateral hypothalamic area (Elias et al., 1998, 1999).
NPY/AgRP neurons directly inhibit POMC neurons and
antagonize the action of aMSH on melanocortin-4
receptors (MC4R) via the release of AgRP (Cone, 2005).
Mutations that abolish the production of leptin, leptin
receptor, MC4R or POMC lead to obesity in rodents and
humans (Cone, 2005; Farooqi and O’Rahilly, 2005; Fried-
man and Halaas, 1998). Although intracerebroventricular
administration of NPY or AgRP leads to a robust feeding
response, decreased energy expenditure, and rapid
weight gain in rodents (Hagan et al., 2000; Qian et al.,
2002; Woods et al., 1998; Wortley et al., 2005), mutations
that prevent the expression of NPY or AgRP have little ef-
fect on feeding behavior. However, loss of Npy does lead
to the attenuation of the obesity syndrome of leptin-
deficient ob/ob mice (Erickson et al., 1996b), and recent
studies have firmly established that NPY/AgRP neurons
are essential for feeding in adult mice since their ablation
has reduced food intake to a much greater extent than
deletion of either Npy or Agrp alone (Gropp et al., 2005;c.
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Bsx in NPY/AgRP Neuron FunctionLuquet et al., 2005), suggesting that NPY/AgRP neurons
may harbor additional molecular players and functions im-
portant for body weight control.
Body weight remains stable when food intake and en-
ergy expenditure are in caloric balance. Energy expendi-
ture can be partitioned into three major categories: basic
cellular and physiological functions that require ATP (rest-
ing thermogenesis), the thermic effect of food, and ther-
mogenesis induced by physical activity (Castaneda
et al., 2005; Tou and Wade, 2002). Although physical
activity expends calories, increased physical activity is es-
sential for food acquisition. Thus, molecular mechanisms
should exist that integrate these complex behaviors in
the service of energy homeostasis. Consistent with that,
both MCH and hypocretin/orexin are important in the con-
trol of locomotory behavior (Georgescu et al., 2005; Marsh
et al., 2002; Thorpe and Kotz, 2005), and leptin signaling in
the arcuate is necessary to maintain normal physical activ-
ity (Coppari et al., 2005).
We have found that the evolutionarily conserved brain-
specific homeobox transcription factor Bsx is expressed
in NPY/AgRP hypothalamic neurons, and that Bsx is
required for normal Npy/Agrp expression, locomotory
behavior, and the physiological response to food depriva-
tion. Mice deficient for both Bsx and leptin have reduced
body weight compared to leptin-deficient animals, and
this is caused by attenuated hyperphagia paralleled by
low Npy/Agrp expression. In contrast, Bsx-deficiency
does not improve locomotor activity in leptin-deficient
mice, revealing an extraordinary function of Bsx in the
molecular regulation of feeding and locomotory behavior.
RESULTS
Downregulation of Npy and Agrp Arcuate Nucleus
Expression in Bsx Mutant Mice
We identified the brain-specific homeobox transcription
factor Bsx in a screen for novel transcriptional regulators
in the hypothalamus. Bsx is expressed from e10.5 in the
ventral diencephalon, an area that gives rise to the hypo-
thalamus (Cremona et al., 2004). In the adult mouse brain,
Bsx expression is restricted to the hypothalamus with
prominent expression in the arcuate nucleus (Figure 1A),
the dorsomedial hypothalamus (DMH), and scattered ex-
pression in the LHA (Figure S1 in the Supplemental Data
available with this article online). Immunofluorescence
staining of adult brain sections with Bsx antibodies faith-
fully recapitulated the Bsx expression pattern obtained
by in situ hybridization (Figure 1B). Subsequent colocali-
zation studies revealed that virtually all arcuate NPY/
AgRP neurons express Bsx and that POMC neurons do
not (Figures 1C–1F).
To assess the role of Bsx in murine development, we
generated two different Bsx alleles, BsxDHD and
BsxH2BeGFP, via homologous recombination in murine em-
bryonic stem (ES) cells (Figures 2A–2F). Using the histo-
ne2BeGFP as a lineage marker, we could independently
demonstrate the hypothalamic-specific expression of
Bsx, consistent with the absence of detectable Bsx ex-Cepression by RT-PCR in other brain regions (Figure S1).
Taking advantage of both Bsx alleles, we established
that loss of Bsx does not lead to a detectable loss of
Bsx-expressing neurons, suggesting that the hypotha-
lamic molecular neuroanatomy remained unchanged
(Figures 2G–2I). This was further substantiated by normal
expression patterns of hypothalamic neuropeptides (Fig-
ure S2). We next examined if loss of Bsx leads to a change
of the gene expression program in NPY/AgRP neurons. In
situ hybridization revealed a strong downregulation ofNpy
expression specifically in the arcuate in Bsx mutant mice
(Figure 3A). Similarly, immunofluorescent staining for
NPY revealed a significant reduction in the arcuate (Fig-
ure 3B). However, NPY staining in the PVN and other
hypothalamic regions was still present, suggesting that
Figure 1. Bsx Expression Pattern in the Arcuate of Adult
Mouse Brains
Arcuate Bsx expression in the adult mouse brain was visualized by (A)
35S in situ hybridization with a Bsx probe and (B) immunohistochemis-
try with a rabbit Bsx antibody. Single-layer confocal images of double
immunofluorescence stainings on coronal brain sections from colchi-
cine-treated 9-week-old wild-type mice with (C) Bsx and NPY, (D)
Bsx and AgRP, (E) Bsx and b-endorphin, and (F) Bsx and a-MSH anti-
bodies detects Bsx expression in NPY/AgRP neurons. Single-layer
confocal projections of double in situ/immunofluorescence analysis
of (G) Npy mRNA or (H) Agrp mRNA and GFP protein on coronal brain
sections from 9-week-old heterozygote BsxH2BeGFP/+ mice.ll Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc. 451
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Bsx in NPY/AgRP Neuron FunctionFigure 2. Generation of BsxDHD and BsxH2BeGFP Alleles
(A) BsxDHD allele was generated fusing the lacZ coding sequence in
frame with the Bsx open reading frame deleting at the same time
part of exon2 which encodes helix 1+2 of the homeodomain.
(B) Genomic DNA was digested with BamHI and probed with a 50 out-
side probe to detect homologous recombination in embryonic stem
cells. PCR analysis was subsequently used for genotyping.
(C and D) Bsx immunostaining on coronal brain sections at the level of
the hypothalamus from a 9-week-old wild-type andBsxDHD/DHD mouse
with a rat Bsx antibody, respectively.
(E) BsxH2BeGFP allele was generated replacing exon1 of Bsx starting at
the ATG with a sequence coding for Histone2BeGFP.
(F) Southern blot analysis of tail DNA digested with HindIII and probed
with a 50 outside probe to detect homologous recombination. PCR
analysis was subsequently used for genotyping.
(G and H) GFP emission from coronal brain sections of 9-week-old
BsxH2BeGFP/+ and mutant BsxH2BeGFP/DHD mice at the level of the arcu-
ate, demonstrating that number of Bsx-expressing neurons within the
hypothalamus are not changed.452 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc.projection of NPY-expressing neurons was not altered
(Figure 3B and data not shown). Expression of Agrp was
also downregulated in Bsx mutant brains (Figure 3C). We
independently confirmed these results by quantitative
RT-PCR which revealed a 5-fold downregulation for hypo-
thalamic Npy and Agrp expression in Bsx mutant animals,
respectively (Figures 3F and 3G). In contrast, but consis-
tent with our immunohistochemical colocalization results,
expression of Pomc and Cocaine-amphetamine regulated
transcript (Cart) was unchanged (Figures 3D, 3E, 3H,
and 3I).
Bsx Mutant Mice Display Altered
Locomotory Behavior
The substantial decrease in Npy and Agrp expression in
Bsx mutant brains prompted us to condust a more
detailed analysis of the metabolic status ofBsxmutant an-
imals. Although body weight ofBsxmutant animals did not
differ from that of their wild-type littermates (Figures 4A–
4C), they had a significant increase in fat mass (Figure 4D).
There was no obvious change in energy expenditure, and
slight decrease in the respiratory quotient (Figures 4E and
4F). Despite the massive downregulation of Npy and Agrp
expression in Bsx mutant mice, the modest change in
physiological parameters is consistent with the modest
phenotype observed in Npy and Agrp knockout animals
(Qian et al., 2002). Unlike what occurs in Npy or Agrp-
deficient mice (Segal-Lieberman et al., 2003b; Wortley
et al., 2005), locomotor activity of Bsx mutant mice was
severely reduced (Figures 4I and 4J). In addition, a signifi-
cant difference in body temperature was observed during
the 12 hr period of darkness between Bsx mutant mice
and their wild-type littermates (Figures 4G and 4H). These
defects in Bsx mutant animals cannot therefore be
explained by a downregulation of Npy or Agrp. The ex-
pression levels of other neuropeptides including MCH or
orexin that are implicated in both feeding and locomotory
behavior were not changed inBsxmutant mice (Figure S2).
Bsx mutant mice were similar to control littermates with
respect to grip strength and performance on a rotarod,
suggesting that motor coordination was not affected
(data not shown).
Bsx mutant mice therefore have downregulated Npy
and Agrp expression, which should reduce food con-
sumption and increase energy expenditure leading to a
lean phenotype, as well as reduced locomotion, which
should decrease energy expenditure and promote body
weight gain. The observed increase in fat mass suggests
therefore that reduced motor activity induced thermo-
genesis is the prevailing of the two metabolic defects on
normal chow.
Fasting Response Is Blunted in Bsx Mutant Mice
Expression of Npy and Agrp is strongly induced when
mice are fasted (Hahn et al., 1998). To determine whether
(I) Counting of GFP-positive nuclei between heterozygoteBsxH2BeGFP/+
and mutant BsxH2BeGFP/DHD in the brain sections reveals no difference
in the number of Bsx-expressing cells in the arcuate.
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Bsx in NPY/AgRP Neuron FunctionFigure 3. Downregulation of Npy and
Agrp Expression in Bsx Mutant Mice
(A) 35S in situ hybridization demonstrates
downregulation of Npy expression specifically
in the arcuate of Bsx mutant brains. (B) NPY
levels are consistent with (A), also reduced.
However the overall NPY staining pattern re-
mains unchanged. Detection and comparison
of (C) Agrp, (D) Pomc1, and (E) Cart expression
levels by 35S in situ hybridization between wild-
type and BsxDHD/DHD mice. Slides hybridized
with all four probes were exposed to emulsion
for 21 days. (F–I) Quantitative real-time PCR for
(F) Npy and (G) Agrp shows a 5-fold downregu-
lation of both transcripts in Bsx mutant mice,
respectively (**p < 0.05). In contrast (H) Pomc
and (I) Cart levels remained unchanged. AU,
arbitrary units.this induction requires Bsx, Npy and Agrp expression de-
termined by 35S in situ hybridization (Figures 5A–5H) and
qRT-PCR (Figures 5I and 5J) was analyzed in wild-type
and Bsx mutant mice after fasting. A robust increase in
Npy and Agrp expression was seen in fasted control ani-
mals (Figures 5B–5F), whereas the absolute levels of
Npy and Agrp in fasted Bsx mutant animals stayed below
the levels of the nonfasted wild-type controls (compare
Figure 5A with Figure 5D and Figure 5E with Figure 5H).
Nonetheless, a reproducible small induction in Npy and
Agrp expression was seen when nonfasted and fasted
Bsx mutant animals were compared (compare Figure 5C
with Figure 5D and Figure 5G with Figure 5H). These re-
sults imply an important, but not exclusive, role for Bsx
in fasting-induced increase of Npy and Agrp gene expres-Csion. The low level of fasting-induced Npy/Agrp expres-
sion prompted us to assess food intake after fasting (‘‘re-
bound feeding’’). Bsx mutant animals ingested 40% less
food than their comparably fasted wild-type littermates,
consistent with the low levels of Npy/Agrp expression
(Figure 5K). These data are in contrast to what has been
observed in mice lacking Npy and/or Agrp, which do not
show reduced rebound feeding (Erickson et al., 1996a;
Qian et al., 2002; Sindelar et al., 2005). One explanation
may be that the low expression of Npy and Agrp still ob-
served in the Bsx mutant mice prevents a network-based
compensatory mechanism as demonstrated in the case of
Npy-deficiency (Luquet et al., 2005). Fasting also in-
creases total dark- and light-phase locomotor activity in
mice (Overton and Williams, 2004; Williams et al., 2003).ell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc. 453
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Bsx in NPY/AgRP Neuron FunctionFigure 4. Reduced Locomotor Activity in Bsx Mutant Mice
(A and B) Average body weight of wild-type (WT), heterozygote, and homozygote female and male mice at the age of 12 weeks old; n = 12 for each
genotype, values are the mean ± SEM.
(C) Average food consumption, determined by measuring 2 day food intake in mice.
(D) Adiposity of the mice was determined by measurements of the fat mass.
(E) Energy expenditure was measured over 2 days and averaged.
(F) Mean respiratory quotient was calculated as the ratio of Vco2 produced/Vo2 consumed over 2 days and averaged. For all the measurements, n = 12
for each genotype both sexes; values represent mean ± SEM, (*p < 0.01). In male and female mice, the tendencies in the three genotypes are the same
for all the measurements, therefore data obtained from female mice are presented.
(G and H) Body core temperature during 12 hr period of darkness as measured by telemetry over a period of 2 days; n > 6 for each genotype, values
are means ± SEM, (*p < 0.01).
(I and J) 48 hr locomotor activity traces determined as number of counts for both male and female mice n = 12 for each genotype and sex. Gray area
represents dark period in (G)–(J).Likewise, Bsx mutant animals did not significantly increase
their home cage activity upon food deprivation, while their
wild-type littermates did (Figures 5L and 5M). These data
further demonstrate the simultaneous dependency on
Bsx function in the behavioral responses to fasting.
The observation that Bsx gene expression itself in-
creases in fasted wild-type mice and in leptin-deficient454 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Incob/ob mice points to another level of regulation for Npy
and Agrp expression (Figure S3). In this respect, it is
also interesting that a highly evolutionarily conserved
Stat3 binding site is located in close proximity down-
stream of the Bsx gene (L.E. and M.T., unpublished data).
Ghrelin, a gut-derived peptide hormone whose circulat-
ing levels increase during fasting, is the only circulating.
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Bsx in NPY/AgRP Neuron FunctionFigure 5. Bsx Is Required for Fasting-Induced Activation of Npy/Agrp Expression
(A–D) Npy 35S in situ expression analysis in nonfasted and 48 hr fasted control and Bsx mutant mice (I) quantification by real-time PCR revealed a
7-fold higher expression of Npy in fasted control compared to Bsx mutant mice (**p < 0.05) and only a 2-fold (#p < 0.05) compared to 3-fold (*p <
0.05) induction of Npy expression comparing Bsx mutant mice with control littermates. (E–H) Agrp 35S in situ expression analysis in nonfasted
and 48 hr fasted control and Bsx mutant mice (J) quantification by real-time PCR revealed a 8-fold higher expression of Agrp in fasted control com-
pared to Bsx mutant mice (**p < 0.05) and only a 2-fold (#p < 0.05) compared to 4-fold (*p < 0.05) induction of Agrp expression comparing Bsx mutant
with control littermates. Slides hybridized with Npy and Agrp probes were exposed for 12 days. Asterisk in (F) marks overexposed and hence black
region due to high-level Agrp expression. (K) 3 hr food intake in control and Bsx mutant male and female mice after 36 hr fasting (rebound refeeding).
(L) 24 hr total activity was significantly increased in both sexes of wild-type but not Bsx mutant mice as compared to baseline levels (*p < 0.05).
(M) both sexes of wild-type but not Bsx mutant animals show strong light phase activity during fasting (locomotor traces are shown only for females).factor that directly stimulates NPY/AgRP neurons (Cowley
et al., 2003; Hewson and Dickson, 2000; Tschop et al.,
2000). It has been shown that the orexigenic action of pe-
ripheral ghrelin is mediated by NPY and AgRP (Chen et al.,
2004). Consistent with the blunted fasting response in Bsx
mutant animals food intake upon ghrelin administration
was significantly lower in Bsx mutant mice compared to
control littermates, although the ghrelin receptor, (growth
hormone secretagogue receptor, Ghsr), is expressed
normally in Bsx-deficient NPY/AgRP neurons (Figure S4).Loss of Bsx Attenuates the Obesity Syndrome
of ob/ob Mice
Similar to food-deprived animals, ob/ob mice lacking lep-
tin have highly elevatedNpy andAgrp expression in the ar-
cuate. To explore the relationship between leptin signaling
and Bsx function, we generated mice mutant for both lep-
tin and Bsx. Double homozygous mutant BsxDHD/DHD;
ob/ob mice were considerably leaner than their ob/ob lit-
termates due to a reduction of fat mass (Figures 6A and
6H). In situ hybridization and qRT-PCR analysis revealedCell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc. 455
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Bsx in NPY/AgRP Neuron FunctionFigure 6. Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Bsx
(A) Physical appearance (picture shows female mice) of control, BsxDHD/DHDob/ob, and ob/ob mice, and body weight of female and male mice at
various ages (A); n = 12 for each genotype; values are the means ± SEM.
(B–D) 35S in situ hybridization forNpy,Agrp and Pomc1 on brain coronal sections from control, ob/ob, and compound mutantsBsxDHD/DHDob/ob. The
slides hybridized withNpy, Agrp, andPomc1were exposed 21 days. Asterisks in (B) and (C) mark the overexposed and hence black region due to high
levels of Npy and Agrp expression.
(E–G) quantitative real-time PCR shows a more than 3-fold difference in Npy (#p < 0.05) and a 6-fold difference in Agrp expression (#p < 0.05) be-
tween ob/ob and control mice and a 19-fold difference in Npy (**p < 0.05) and a 28-fold difference in Agrp expression (**p < 0.05) between ob/ob
and BsxDHD/DHDob/ob mice, whereas Pomc1 expression levels remained unchanged.456 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc.
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Bsx in NPY/AgRP Neuron Functionthat expression of Npy and Agrp did not exceed the low
levels observed in Bsx mutant animals and were not in-
creased as observed in ob/ob animals (compare Figures
6B, 6C, 6E, and 6F with Figures 3A, 3C, 3F, and 3G). No
difference was detected in Pomc expression between
ob/ob and BsxDHD/DHD;ob/ob mice, which was lower
than in wild-type controls in both cases (Figure 6D and
6G). Consistent with the downregulation of Npy expres-
sion inBsxDHD/DHD;ob/ob mice, food intake was increased
by only 20% compared to control littermates, whereas ob/
ob mice ingested 70% more food (Figure 6I). Thus,
BsxDHD/DHD;ob/ob mice have a considerably reduced
hyperphagia (60%). Body temperature in BsxDHD/DHD;
ob/ob mice was elevated compared to that of ob/ob
mice, which may reflect a partial rescue of impaired rest-
ing thermogenesis (Figure 6J).
Since glucose homeostasis and glycemic control are
improved in ob/ob mice which are also deficient for Npy
(ob/ob;Npy/) (Erickson et al., 1996b), we measured
these parameters in the BsxDHD/DHD;ob/ob animals. Loss
ofBsx significantly ameliorated the hyperglycemia and hy-
perinsulinemia observed in ob/ob animals. Fertility of ob/
ob females was also improved by removal of Bsx, similar
to what had been observed for ob/ob;Npy/ mice (Table
S1). Despite the significant weight reduction in BsxDHD/DHD;
ob/ob mice, locomotor activity levels were not higher
compared to ob/ob mice (Figures 6K and 6L). This result
implies that Bsx function is an essential genetic compo-
nent and independent determinant in the hypothalamic
regulation of locomotory behavior.
Bsx Occupies Npy and Agrp Regulatory Sequence
Elements In Vivo
The low expression of Npy and Agrp after fasting in Bsx
deficient mice and in BsxDHD/DHD;ob/ob double-mutant
mice suggested that Bsx may directly regulate Npy and
Agrp expression. Rat PC12 cells, which express Npy at
low levels (Higuchi et al., 1988), do not express endoge-
nous Bsx (data not shown). We therefore hypothesized
that expression of Bsx in PC12 cells would stimulate
Npy expression. Quantitative RT-PCR revealed a 50-fold
induction of Npy in cells transfected to express Bsx over
the signal that was detected in mock-transfected cells
(Figure 7A). To see if this induction is specific to Bsx or if
other homeobox transcription factors could produce sim-
ilar effects, we used the closely related homeobox gene
Nkx2.1/TTF-1, which is coexpressed during development
in the hypothalamus, as a control. Overexpression of
Nkx2.1 or another control, Pit-1, led to only a modest in-
crease in Npy RNA of 4- or 2-fold, respectively (Figure 7A).
Activation of Npy expression can also be mimicked by
treating PC12 cells with the cAMP analog DibcAMP and
further stimulated with PMA (Higuchi et al., 1988), consis-Ctent with reports implicating the transcription factor CREB
in Npy regulation during starvation (Shimizu-Albergine
et al., 2001). We repeated this experiment in PC12 cells
and found that Npy expression was activated about the
same level by DibcAMP/PMA treatment as in the Bsx
transfection experiment. Unexpectedly, when we stimu-
lated Bsx-transfected PC12 cells with DibcAMP/PMA,
we observed a synergistic increase in Npy expression
(Figure 7A). Using reciprocal GST pull-down experiments,
we found that Bsx and CREB physically interact (Fig-
ure 7E). To identify the regulatory sequences to which
CREB and Bsx bind in the Npy promoter region we took
a bioinformatic comparative sequence analysis approach.
Aligning various mammalian species only one region ap-
proximately 50kb upstream of the Npy gene start site
could be identified that is conserved and contained a con-
served CREB and homeobox binding site next to each
other (Figures 7B and S5). When we tested this DNA frag-
ment in front of a basal promoter driving luciferase we
could recapitulate the synergistic activation seen in
PC12 cells of the Npy gene by Bsx and cAMP (Figure 7C).
Furthermore, chromatin immunprecipitation (ChIP) using
a Bsx-specific antibody on H2BeGFP-positive cells sorted
from heterozygote and Bsx mutant animals demonstrated
occupancy of the predicted homeobox binding site by Bsx
in vivo (Figure 7D).
Analogously, it has been reported that FoxO1 translo-
cates to the nucleus during fasting where it stimulates
Agrp gene expression (Kitamura et al., 2006). This can
be mimicked using a constitutive FoxO1-ADA expression
vector. We therefore transfected AtT20 cells with combi-
nations of Bsx and FoxO1 expression vectors and found
that Bsx and FoxO1 cooperate to induce Agrp expression
(Figure 7G). Close to the reported FoxO1 and Stat3 bind-
ing sites there are two highly conserved homeobox bind-
ing sites in mammals (C.B. Kaelin and G.S. Barsh, per-
sonal communication) (Figure 7H). Employing a similar
approach as for the Npy element we could demonstrate
that these sites are occupied by Bsx in vivo and are able
to act in concert with the neighboring FoxO1 site in Agrp
gene induction (Figures 7I and 7J). Furthermore, using
GST pull-down experiments, we also found that Bsx and
FoxO1 physically interact (Figure 7K). These results to-
gether indicate that Bsx can directly stimulate Npy and
Agrp expression and is able to physically interact with
the two transcription factors CREB and FoxO1 that have
been implicated in the fasting dependent up-regulation
of these neuropeptides.
DISCUSSION
Hypothalamic neurons producing NPY and AgRP have re-
cently been confirmed as essential centers of food intake(H) Adiposity was determined by fat mass measurements of mice from each genotype at 16 weeks of age; values represent means ±SEM, (*p < 0.01,
#p < 0.01).
(I) Food intake was determined by monitoring of food intake over 2 days; n > 9 for each genotype, values are the means ± SEM, (*p < 0.01, #p < 0.01).
(J) Body core temperature as measured by telemetry over a period of 2 days; n > 9 for each genotype, values are means ± SEM, (*p < 0.01, #p < 0.01).
(K and L) 48 hr locomotor activity traces for male and female mice of the indicated genotypes; n = 6 for every genotype.ell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc. 457
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Bsx in NPY/AgRP Neuron FunctionFigure 7. Regulation of Npy and Agrp Gene Expression by Bsx
(A) Npy expression analysis using quantitative RT-PCR from PC-12 cells transiently transfected with Bsx, Pit1, and Nkx2.1 expression vectors and/or
treated with PMA and/or DibcAMP; data were normalized for TBP (**p < 0.01).
(B) Sequence of the Npy regulatory element containing the conserved Bsx and CREB binding sites.
(C) Activation of a heterologous promoter driven by the Npy regulatory element in PC12 cells.
(D) Chromatin immunoprecipitation using a Bsx specific antibody shows occupancy of Bsx on the predicted binding site in isolated H2BeGFP labeled
hypothalamic cells from heterozygous but not Bsx mutant mice.
(E) GST pull-down interaction assay with GST::Bsx and in vitro translated full length CREB protein, and GST::CREB with in vitro translated Bsx protein.
(F) Model of Npy gene regulation.
(G) Agrp expression analysis using quantitative RT-PCR from AtT20 cells transiently transfected with Bsx and FoxO1 expression vectors; data were
normalized for 18S (**p < 0.01).
(H) Sequence of the Agrp regulatory element containing the conserved Bsx, FoxO1, and Stat3 binding sites.
(I) Activation of a heterologous promoter driven by the Agrp regulatory element in AtT20 cells.458 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc.
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Bsx in NPY/AgRP Neuron Functionand body weight regulation (Gropp et al., 2005; Luquet
et al., 2005). The most powerful signals known to activate
these arcuate neurons are food deprivation or administra-
tion of ghrelin (Cowley et al., 2003; Hahn et al., 1998). The
present data indicate that the brain-specific homeobox
transcription factor Bsx is required for adaptive increases
in Npy and Agrp expression, ghrelin stimulated food in-
take, and for a normal hyperphagic response to fasting.
Since deficiency for Bsx also rescues the hyperphagia of
leptin-deficient mice similar to what has been observed
in ob/ob mice with Npy deficiency (Erickson et al., 1996b),
we conclude that Bsx may also be required for nonphysio-
logical types of hyperphagia. However,Bsxmutant mice in
addition show a reduction in Agrp expression. As AgRP
plays a well-known function in melanocortin signaling
(Cone, 2005), it may be interesting to see if Bsx deficiency
also ameliorates the obesity phenotype of melanocortin-4
receptor mice which is in part caused by hyperphagia
(Huszar et al., 1997). Interestingly, MC4R mutant mice do
show de novo expression of Npy in the DMH region where
Bsx expression is also observed (Kesterson et al., 1997).
Despite the central importance of the two orexigenic
peptides NPY and AgRP for food intake and energy me-
tabolism their signal-dependent transcriptional regulation
is still not fully understood. In case of Agrp gene regula-
tion, elegant genetic experiments have shown that leptin
receptor-dependent Stat3-signaling is modulating Agrp
expression (Bates et al., 2003). More recent in vivo studies
have confirmed an essential role for cis-acting Stat3 bind-
ing sites in the regulation of Agrp, but also proposed a
requirement for additional factors (Kaelin et al., 2006). In-
deed, subsequent work has shown that FoxO1, the distal
effector of insulin signaling, activatesAgrp expression and
that leptin signaling through Stat3 can inhibit FoxO1 func-
tion by a transcriptional squelching mechanism (Kitamura
et al., 2006). In contrast, the transcriptional regulation of
Npy gene expression in vivo is less clear than for Agrp.
In particular, the demonstrated inhibition of Npy gene ex-
pression by leptin, which requires PI3K signaling, is not
well understood at the transcriptional level (Morrison
et al., 2005; Xu et al., 2005). The identification of an evolu-
tionary conserved regulatory cis-acting element approxi-
mately 50 kb upstream of the Npy transcriptional start
site which is bound by Bsx in vivo will now allow similar
in vivo studies as mentioned above for Agrp. Our study
thus adds Bsx to the transcriptional network required for
Agrp and Npy gene expression. The highly restricted
Bsx expression pattern provides tissue specificity that
may work in the context of more generally required tran-
scriptional regulators such as CREB, Stat3 and FoxO1.
This situation resembles the roles of other homeodomain
transcription factors in other organ systems (Scully and
Rosenfeld, 2002).CeThe phenotypic analysis of Bsx mutant mice indicates
that Npy and Agrp expression as well as hypothalamic
control of locomotory behavior depends on Bsx function.
Mice deficient for Bsx lose 50% of their spontaneous
physical activity and fail to increase home cage activity
upon food deprivation. That locomotory behavior and
body weight control might rely on overlapping hypotha-
lamic neuronal networks is supported by analysis of other
mouse mutants.
For example, Leptin-deficient mice also have de-
creased locomotor activity. However, rescue of leptin sig-
naling in mice deficient for leptin or the leptin receptor nor-
malizes their locomotor activity before any benefits in
terms of weight reduction can be observed, pointing to-
ward a body weight-independent neuroendocrine control
of spontaneous physical activity (Coppari et al., 2005;
Pelleymounter et al., 1995). The existence of an as yet un-
known hypothalamic control of locomotor acitivity would
be consistent with the observation that caloric restriction
leads to an immediate change in locomotory behavior of
rodents. An essential requirement for Bsx function in loco-
motory behavior control is further supported by the
BsxDHD/DHD;ob/ob phenotype, where locomotor activity
of ob/ob mice was not increased despite a significant re-
duction in body weight. Furthermore, it is well established
that loss of MCH improves locomotor activity in ob/ob
mice, and that this reduces their obesity syndrome
(Segal-Lieberman et al., 2003a). In addition, disruption of
the MCH receptor 1 has been reported to lead to hyperac-
tivity (Marsh et al., 2002). Interestingly, NPY/AgRP neu-
rons have projections to MCH-expressing neurons in the
LHA (Elias et al., 1999). Consequently, NPY/AgRP neurons
may modulate the dopaminergic system through MCH-
expressing neurons; this circuit would represent a major
component within the CNS network that regulates loco-
motory behavior (Zhou and Palmiter, 1995).
Although we favor the interpretation that the main loco-
motory behavior phenotype in Bsx mutant mice originates
in the NPY/AgRP neurons (Coppari et al., 2005) there are
two other Bsx-expressing neuronal populations located
in the DMH and LHA of the hypothalamus that could con-
tribute to the locomotory behavior phenotype of Bsx mu-
tant mice. In particular, lesion studies of the DMH have
demonstrated an involvement of this region in food-en-
trainable circadian rhythms (Gooley et al., 2006). However,
it is hard to address if Bsx-positive neurons in the DMH are
required for circadian food entrainable rhythms due to the
low amplitude of locomotor activity seen in Bsx mutant
mice. Similarly, a small population of Bsx-expressing neu-
rons in the LHA is directly intermingled with MCH- and
Orexin-expressing neurons and may directly influence
these neuronal populations (Figures S1J and S1K). Thus,
the individual contribution of each of these Bsx-positive(J) Chromatin immunoprecipitation using a Bsx specific antibody shows occupancy of Bsx on the predicted binding site in isolated H2BeGFP labeled
hypothalamic cells from heterozygous but not Bsx mutant mice.
(K) GST pull-down interaction assay with GST::Bsx and in vitro translated full length FoxO1 protein and GST::FoxO1 with in vitro translated Bsx
protein.
(L) Model of Agrp gene regulation.ll Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc. 459
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type inBsxmutant mice awaits genetic dissection. Recent
studies have suggested that wide differences in spontane-
ous physical activity observed in humans may be biologi-
cally rather than environmentally determined (Levine et al.,
2005; Wilkin et al., 2006). The current data support the
hypothesis that Bsx activity is one important molecular
determinant of calorically relevant locomotory behavior.
Future studies on the regulation of Bsx activity and the
transcriptional network underlying NPY/AgRP physiology
may provide new insight into the mechanisms that are
responsible both for adaptive hyperphagia as well as
spontaneous physical activity and might open new ave-
nues to control obesity. Finally, the homeobox in Bsx is
highly conserved among Drosophila, C.elegans, fish and
mammals (Jones and McGinnis, 1993). This raises the
possibility that Bsx might be part of an evolutionarily




Mice were housed in specific pathogen-free, light (12 hr light/dark cy-
cle), temperature- (23C) and humidity- (50%–60% relative humidity)
controlled conditions. Animals were fed with regular chow diet (Harlan
Winkelmann, Teklad, TD2018S); food and water were always freely
available except where otherwise indicated. The procedures for per-
forming animal experiments were in accordance with the principles
and guidelines of the LAR/EMBL. The BsxDHD allele was backcrossed
for at least 10 generations to C57/BL6J before the physiological
measurements and interbreeding with ob mice were performed. The
BsxH2beGFP allele is on a mixed 129Sv/C57BL6J background. Mice
carrying the ob mutation were obtained from Jackson Laboratories
(ME, USA).
Generation of Bsx Alleles
BsxDHD and BsxH2beGFP alleles were generated using standard mouse
embryonic stem cell technology using R1 ES cells. 129 BAC was
isolated and an 8 kb BamHI-fragment was subcloned containing the
Bsx genomic locus. Detailed description and genotyping strategy
can be found in Supplemental Experimental Procedures.
Combined In Situ Hybridization Immunohistochemistry
Anesthetized animals were transcardially perfused with 10% formalin;
the brains were removed and postfixed over night at 4C with 10% for-
malin. Hybridization with 35S-UTP labeled (GE/Amersham Bioscience)
antisense RNA probes was performed on 18 mm cryosections as pre-
viously described (Treier et al., 1998). Images were captured by using
a Leica DC 500 camera attached to a Zeiss axiophot compound micro-
scope.
For the fluorescent in situ hybridization, antisense RNA probes were
labeled with digoxigenin-UTP (Roche Diagnostics) according to the
manufacturer’s protocol. Immunological detection of digoxigenin-
labeled probes was performed according to manufacturer’s protocol
(Roche Diagnostics). Immunological detection of GFP was performed
with a primary rabbit antibody against GFP (1:400 dilution, Torey Pines)
incubated simultaneously with the anti-digoxigenin antibody. After
color development with FastRed tablets (Roche Diagnostics), the reac-
tion was stopped and the sections were incubated with a secondary
FITC coupled antibody (1:400 dilution, Molecular Probes) for 1 hr at
RT. Sections were next washed 3 times in PBS containing 1%Triton-X
and mounted with Mowiol for microscopy. Images were captured by
using a Leica TCS SP2 confocal Laser scanning microscope.460 Cell Metabolism 5, 450–463, June 2007 ª2007 Elsevier Inc.Measurement of Neuropeptide mRNA Levels
Bsx mutant and littermate controls were euthanized by cervical dis-
location, and RNA was extracted from hypothalamic wedges using
Qiagen RNAeasy kit.
Relative mRNA expression was determined by quantitative RT-PCR
on an ABI Applied Biosystems 7500 instrument using ABI SYBR green
PCR master mix. Data analysis was done using relative expression
software tool, REST (Pfaffl et al., 2002) using Gapdh and b-actin as
the reference genes. Oligonucleotide primer sequences can be found
in Supplemental Experimental Procedures.
Immunohistochemistry
Anesthetized mice were perfused transcardially with PBS containing
2% paraformaldehyde. The brains were removed and postfixed over
night in 2% paraformaldehyde. For double immunohistochemistry,
free-floating 50 mm vibrotome sections were used (Leica VT1000S).
Sections were next incubated in blocking solution (PBS containing
0.4% Triton-X, 5% serum corresponding to the secondary antibody)
for 1 hr at room temperature followed by over night incubation with
the primary antibodies at 4C. The sections were washed the next
day (0.4% Triton-X in PBS) and incubated for 1 hr at room temperature
with the secondary antibodies. Bsx was detected with two antibodies
we generated, an antibody raised in rabbit, immunized and boosted
with the full-length protein Bsx and diluted 1:200, and a second spe-
cific antibody raised in rat immunized and boosted with a truncated
form of Bsx containing only the Carboxy terminus of the protein diluted
1:100. NPY was detected with a rabbit anti-NPY (1:200 dilution, Pen-
insula Laboratories Inc, Bachem), AgRP with a rabbit anti-AgRP
(1:200 dilution, Alpha Diagnostic international), b-endorphin with a
rabbit anti-bendorphin (1:500 dilution, Parlow), a-MSH with a sheep
anti-a-MSH (1:5000, Chemicon International), and Fos with a rabbit
anti-Fos (1:500, Oncogene Research products). The secondary anti-
bodies used were: Cy3-labeled anti-rabbit Immunoglobin G (IgG),
Cy3-labeled anti-rat IgG, FITC-labeled anti-sheep, Cy2-labeled
anti-rabbit IgG, Cy3-labeled anti chicken IgG (all by Jackson Immuno-
Research raised in Donkey).
Colchicine Administration
For the colocalization immunohistochemistry performed for Bsx and
the hypothalamic neuropeptides, wild-type mice were treated with
Colchicine (Sigma) in order to enhance cell-body staining 24 hr before
the perfusion. 60 mg Colchicine (10 mg/ml in 0.9% saline) has been ad-




Body fat mass was measured in all mice on day 75 of age in duplicates
using Nuclear Magnetic Resonance (QMR, EchoMRI, Quantitative
Magnetic Resonance Body Composition Analyzer, Echo Medical Sys-
tems, Houston, TX, USA [Taicher et al., 2003; Tinsley et al., 2004]),
which allows repeated measurements in conscious animals. Lean
mass was calculated by subtracting fat mass from body weight
measured prior to NMR measurement.
Locomotor Activity
Gross locomotor activity of mice was measured using biotelemtry (Mini
Mitter Co., Inc., Bend, OR, USA). This system requires implantation of
transponders into the abdominal cavity and the mouse cage to be
placed on a receiver. The current location of the transponder signal
on the receiver area compared to the previous measurement is inter-
preted as movement. Localization of the transponder signal on the
receiver was measured every 5 min. A second technique for the mea-
surement of mouse locomotor activity within home cage environment
was based on number of breaks of an infrared light beam system (TSE,
Bad Homburg) and was used for confirmation of principal findings as
well as for the quantification of fasting induced stimulation of loco-
motor activity.
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Energy expenditure was measured by indirect calorimetry using a self-
constructed system equipped with the gas analyzing system Advance
Optima from ABB AG (Mannheim, Germany, formerly Hartmann &
Braun). The system provides one measurement every 6 min per
cage. Energy expenditure of mice was evaluated at the age of 8–12
weeks. Mice were adapted to respiratory cages for 2 days. Adaptation
was followed by a 2 day measurement period. Before and after the
measurement period, mice were analyzed for body composition using
Nuclear Magnetic Resonance imaging for calculation of lean mass-
specific energy expenditure.
GST Pull-Down Assay
In brief, after purification with glutathione sepharose beads, GST and
GST fusion proteins were loaded on an SDS-acrylamide gel for quan-
tification. 2 mg of protein coupled with the matrix were used in each
sample. The full-length mouse Bsx, CREB, and FoxO1 proteins were
expressed and purified as GST fusions proteins in the pET-41a-c
bacteria vector (Novagen). GST::Bsx, GST::CREB and GST::FoxO1
were added to the standard GST pull-down with in vitro translated
CREB, full length Bsx or FoxO1 labeled with Methionine-35S (in vitro
translation kit: TNT coupled reticulocyte lysate systems, Promega,
Methionine-35S from Amersham). The reaction was allowed to proceed
for 2 hr at 4C in PBS 0.1% Tween w/w. Samples were next washed
5 times with PBS containing 0.5% Tween w/w and loaded on a SDS-
acrylamide gel. The data were then analyzed by autoradiography.
Cell Culture-qRT-PCR Analysis
AtT20 cells and PC-12 cells were obtained from ATCC and transfected
with lipofectamin 2000 (Invitrogen). Cells were treated with Phorbol-
12-myristate-13-acetate (PMA, Sigma) and 20-0-Dibutryladenosine-
30,50-cyclic-monophosphate sodium salt (DibcAMP, Sigma) as
indicated. QRT-PCR was performed to quantify Npy and Agrp
mRNA isolated from PC-12 and AtT20 cells, respectively. Primers
are listed in Supplemental Experimental Procedures.
ChIP Assays
‘‘Carrier’’ ChIP assay was performed on 25,000 FACS sorted GFP-
positives neurons from 12 BsxH2BeGFP/+ and 12 BsxH2BeGFP/DHD mice
(O’Neill et al., 2006). GFP-positive neurons were sorted on a modified
Dako MoFlo sorter (DAKO GmbH, Hamburg Germany D-22083). The
primers used for Agrp: 50-CGGAAGGGAGCAGCCAT-30 (forward)
and 50-TCCTGGCTCTCCCTCCT-30 (reverse) (676 to479) and con-
trol: 50-GCAGACAGCATCCAG-30 (forward) and 50-CGATGGAACATC
CAGT-30 (reverse) (11.3 to 11.4 kb). For Npy: 50-GCAGCCTTCA
TATCG-30 (forward) and 50-GCTCTGTGATGTTC-30 (reverse) (48.5
to 48.3 kb) and control: 50-GCATGGCTCACCAT-30 (forward) and
50-CCAGCCAGCCCAGTA-30 (reverse) (59.9 to 59.7 kb). The rabbit
antibody against Bsx was used for the IP and the rabbit antibody
against GFP was used for the mock control IP.
Luciferase Assays
AtT20 or PC12 cells were transfected with luciferase reporter con-
structs containing the Agrp promoter (nucleotides 700 to 1) or the
Npy cis-regulatory modules (48,823 to 48,174) along with control,
Bsx and/or FoxO1-ADA expression vectors. Renilla plasmid (Promega)
was cotransfected as control for transfection efficiency. Cells were
treated with Phorbol-12-myristate-13-acetate (PMA, Sigma) and
20-O-Dibutyryladenosine-30, 50-cyclic-monophosphate sodium salt
(Dibc AMP, Sigma) as indicated. Luciferase activity was determined
using the Dual-Luciferase Reporter Assay kit (Promega).
Statistical Analyses
Data are presented as means ± SEM. All data were normally distrib-
uted. Two-sample t test was applied to calculate significance between
the fat mass of BsxDHD/DHD and the control wild-type. Analysis of var-
iance was calculated by applying Kruskal-Wallis tests (for the refeed-
ing and locomotion measurements during the fasting experiment, forCthe real-time PCR data, the fat mass, food intake, and body tempera-
ture measurements of the double-mutant BsxDHD/DHD ob/ob mice, and
the endocrine parameters measurements). The test was followed by
Tukey’s post hoc tests (for the real-time PCR data, the fat mass,
food intake, and body temperature measurements of the double-
mutant BsxDHD/DHD ob/ob mice, and the endocrine parameters mea-
surements). For all analyses, significance was assigned at the p <
0.05 level.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, five figures, and one table and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/
full/5/6/450/DC1/.
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